New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:07 EDTAEGR, SLF, SRC, QTNT, SABR, PFE, FRSH, OILT, MFC, GPT, BKW, ARES, AWH, TRXCOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aegerion (AEGR) initiated with a Sell at Goldman... Allied World (AWH) initiated with a Buy at CRT Capital... Ares Management (ARES) initiated with a Buy at BofA/Merrill... Burger King (BKW) initiated with an Equal Weight at Morgan Stanley... Gramercy Property Trust (GPT) initiated with a Buy at BofA/Merrill... Manulife Financial (MFC) initiated with a Buy at Canaccord... Oiltanking Partners (OILT) initiated with a Market Perform at Wells Fargo... Papa Murphy's (FRSH) initiated with a Buy at Jefferies... Pfizer (PFE) reinstated with a Buy at Goldman... Quotient (QTNT) initiated with a Buy at UBS... Sabre (SABR) initiated with a Buy at BofA/Merrill... Spirit Realty (SRC) initiated with a Neutral at BofA/Merrill... Sun Life Financial (SLF) initiated with a Buy at Canaccord... TransEnterix (TRXC) initiated with an Outperform at RBC Capital.
News For AEGR;AWH;ARES;BKW;GPT;MFC;OILT;FRSH;PFE;SABR;QTNT;SRC;SLF;TRXC From The Last 14 Days
Check below for free stories on AEGR;AWH;ARES;BKW;GPT;MFC;OILT;FRSH;PFE;SABR;QTNT;SRC;SLF;TRXC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
August 25, 2014
08:36 EDTBKWTim Hortons business would be boosted by Burger King deal, says KeyBanc
Subscribe for More Information
06:47 EDTBKWTim Hortons volatility expected to move on confirming talks with Burger King
Subscribe for More Information
06:29 EDTPFEPfizer mulls possible AstraZeneca offer options, FT says
Subscribe for More Information
05:11 EDTBKWTim Hortons, Burger King confirm talks regarding potential strategic transaction
Subscribe for More Information
August 24, 2014
20:05 EDTBKWBurger King seeks Tim Hortons acquisition in tax inversion deal, WSJ says
Subscribe for More Information
August 22, 2014
14:19 EDTPFEViiV Healthcare receives FDA approval for HIV-1 treatment Triumeq
Subscribe for More Information
10:52 EDTBKWCarrols Restaurant signs agreements to buy 64 Burger King restaurants
Subscribe for More Information
06:23 EDTAWHAllied World to host conference call
Conference call to discuss agreement to acquire RSA Singapore and Hong Kong will be held on August 25 at 9 am. Webcast Link
August 21, 2014
17:28 EDTAWHAllied World to acquire Hong Kong, Singapore operations of RSA for $215M
Subscribe for More Information
13:32 EDTPFEBristol-Myers, Pfizer announce approval of Eliquis for treatment of DVT, PE
Subscribe for More Information
09:54 EDTPFEPotential Pfizer, AstraZeneca deal seen around year-end, Reuters says
Investors and analysts see Pfizer (PFE) making another attempt to acquire AstraZeneca (AZN) around year-end, even though talks between the two can resume on August 26 per British takeover rules, Reuters reports. Reference Link
08:02 EDTPFEPfizer initiates U.S. EAP for palbociclib.
Pfizer announced that the company has initiated a multi-center, open-label expanded access program in the U.S. for palbociclib. Through the program, palbociclib is being made available for use in combination with letrozole for post-menopausal women with hormone receptor positive human epidermal growth factor receptor 2 negative advanced breast cancer for whom letrozole is considered appropriate therapy.
07:55 EDTPFEActavis volatility expected to move on Pfizer considering new target report
Actavis (ACT) volatility is expected to move on Pfizer (PFE) considering other overseas alternatives, Bloomberg reports. Overall option implied volatility of 27 is near its 26-week average of 31 according to Track Data, suggesting decreasing price movement.
07:47 EDTPFEPfizer looking at new targets, including Actavis, Bloomberg reports
While it weighs another attempt to acquire AstraZeneca (AZN), Pfizer is considering other overseas alternatives, including Actavis (ACT), Bloomberg reports, citing people familiar with the matter. Pfizer prefers to reach a deal with AstraZeneca, and a move on another company is unlikely "anytime soon," Bloomberg adds, citing its sources. Shares of Actavis are rising 3%, or $6.65, to $230.01 in pre-market trading, while AstraZeneca is up 2% to $72.59. Reference Link
August 20, 2014
08:31 EDTGPTGramercy Property Trust acquires cold storage facility for $19.1M
Subscribe for More Information
08:03 EDTPFEBristol-Myers Pfizer to present new Eliquis data
Subscribe for More Information
August 19, 2014
07:09 EDTOILTCitigroup to hold a conference
MLP / Midstream Infrastructure Conference to be held in Las Vegas on August 19-21.
August 18, 2014
11:41 EDTPFECubist rises after report sparks takeover interest speculation
Subscribe for More Information
08:01 EDTPFEPfizer announces submission of Palbociclib NDA to FDA
Pfizer announced it has completed the submission of a New Drug Application to the United States Food and Drug Administration for palbociclib. This NDA requests FDA approval of palbociclib, in combination with letrozole, for the treatment of postmenopausal women with estrogen receptor positive, human epidermal growth factor receptor 2 negative advanced breast cancer who have not received previous systemic treatment for their advanced disease. The submission is based on the final results of PALOMA-1, a randomized, Phase 2 trial comparing palbociclib plus letrozole versus letrozole alone in this population of patients. Palbociclib received Breakthrough Therapy designation from the FDA in April 2013, for the first-line systemic treatment of women with advanced or metastatic ER+, HER2- breast cancer. This designation was based on interim data from the PALOMA-1 trial. The FDA has a 60-day filing review period to determine whether the NDA is complete and acceptable for filing. Pfizer will communicate the Agency’s decision.
07:57 EDTPFECambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use